Jab that is part of global initiative to distribute doses will remain at low price ‘in perpetuity’
The coronavirus vaccine produced by Oxford University and AstraZeneca will be available at cost – not for profit – “in perpetuity” to low and middle income countries in the developing world.
The details of arrangements to supply poorer countries came as AstraZeneca revealed the interim results of phase 3 trial of a vaccine that is being heralded as being the first to meet the more challenging requirements of the developing world.
Continue reading…Jab that is part of global initiative to distribute doses will remain at low price ‘in perpetuity’Coronavirus – latest updatesSee all our coronavirus coverageThe coronavirus vaccine produced by Oxford University and AstraZeneca will be available at cost – not for profit – “in perpetuity” to low and middle income countries in the developing world.The details of arrangements to supply poorer countries came as AstraZeneca revealed the interim results of phase 3 trial of a vaccine that is being heralded as being the first to meet the more challenging requirements of the developing world. Continue reading…